InsidersTradesSigma
RemeGen Co., Ltd. Stock: price and management transactions · Hong Kong · HKEX
Follow the RemeGen Co., Ltd. share price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the authority of HKEX. Operating in the Health Care sector, RemeGen Co., Ltd. has published 53 insider filings. Market capitalisation: €49.7bn. The latest transaction was disclosed on 24 April 2026 (Sale). Among the most active insiders: Lin Jian. All data is accessible without an account.
53
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€37m
53 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate RemeGen Co., Ltd. Buy (bullish), based on 14 analysts. Average price target: HK$114.45.
4Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 11,847 of 26,270 companies
54.5
score / 100
Value27
Quality82
FCF yld-0.3%
Earn yld1.4%
EV/EBITDA47.2x
ROE45%
Gross mgn87%
Net mgn22%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 April 2026
Declarations53 total
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00706
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00726
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00682
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00764
10,000 shares@ HK$90.07251.3% of flowShareXHKGHKEX:DA20260423E00758
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00759
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00755
20,000 shares@ HK$97.202.9% of flowShareXHKGHKEX:DA20260423E00709
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00712
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00707
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00705
60,000 shares@ HK$86.007.7% of flowShareXHKGHKEX:DA20260423E00704
60,000 shares@ HK$85.007.7% of flowShareXHKGHKEX:DA20260423E00703
100,000 shares@ HK$108.49616.0% of flowShareXHKGHKEX:DA20260423E00701
53,000 shares@ HK$91.94347.2% of flowShareXHKGHKEX:DA20260423E00729
160,000 shares@ HK$89.2521.4% of flowShareXHKGHKEX:DA20260423E00722
60,000 shares@ HK$103.009.2% of flowShareXHKGHKEX:DA20260423E00724
25 of 53 declarations
About RemeGen Co., Ltd.
RemeGen Co., Ltd. is a Chinese biopharmaceutical company focused on the research and development of treatments for cancer and other serious diseases. It is listed on the Hong Kong Stock Exchange under the H Shares symbol.